10.1002/ejoc.201701426
European Journal of Organic Chemistry
FULL PAPER
4.20 (dd, J = 4.8 and 11.5, 2H), 3.71 (d, J = 13.6, 2H), 3.66 (d, J = 13.6,
2H), 3.39 (t, J = 6.5, 4H), 3.29-3.21 (m, 2H), 3.05 (dd, J = 7.2 and 13.1,
2H), 2.74 (dd, J = 7.2 and 13.1, 2H), 2.35 (t, J = 7.4, 4H), 2.25 (s, 6H),
1.92-1.82 (m, 4H), 1.72-1.61 (m, 4H), 1.54-1.43 (m, 4H). 13C NMR (100
MHz, CDCl3) δ: 173.1, 139.2, 128.5, 128.2, 127.0, 62.6, 60.6, 58.5, 38.3,
37.0, 34.0, 33.5, 32.3, 27.6, 24.0. HRMS calculated for
[C34H50Br2N2O4S2]+: 772,1579; obtained: 772,1593.
A round-bottomed flask, equipped with reflux condenser, was charged
with the bromide, acetonitrile and 1,2-dimethylimidazole. This solution
was stirred at 60 °C for 24 hours. Then, the solvent was evaporated and
the yellow oil was dried under vacuum.
1-{(R,R’)-bis-[2-(N-benzyl-N-methylamino)-3-hexanoate-
propyl]dissulfide}-2,3-dimethylimidazolium bromide (1a)
(4R)-3-benzyl-thiazolidin-4-yl-methyl 6-bromohexanoate (9)
Reagents and amounts used: Bromide 7 (0.36 g, 0.46 mmol), 1,2-
dimethylimidazole (0.18 g, 1.84 mmol) and acetonitrile (10 mL). The
yellow oil obtained consist of a mixture of the ionic product and the
unreacted 1,2-dimethylimidazole in the proportion of 1:1.1 (ionic product:
Reagents and amounts used: 6-bromohexanoic acid (0.21 g, 1.09 mmol),
dry CH2Cl2 (8 mL), EDCI (0.17 g, 0.91 mmol), DMAP (catalytic) and
alcohol 8 (0.18 g, 0.91 mmol) obtained in two steps from disulfide 5 as
1
20
1,2-dimethylimidazole) calculated by H NMR. Yield: >99%. []D = +13
previously described[4a]
.
The residue was purified with column
(c 1.0, MeOH). *Product: H NMR (400 MHz, CDCl3) δ: 7.70 (d, J = 2.0,
1
chromatography using the mixture ethyl acetate:hexane 10:90 as eluent
2H), 7.64 (d, J = 1.8, 2H), 7.42-7.15 (m, 10H), 4.37-4,14 (m, 8H), 3.98 (s,
6H), 3.67 (quart, J = 13.6, 4H), 3.28-3.17 (m, 2H), 3.03 (dd, J = 6.9 and
13.2, 2H), 2.79 (s, 6H), 2.74 (dd, J = 7.4 and 13.2, 2H), 2.39-2.31 (m, 4H),
2.24 (s, 6H), 1.85 (q, J = 7.4, 4H), 1.65 (q, J = 7.4, 4H), 1.50-1.36 (m, 4H).
13C NMR (100 MHz, CDCl3) δ: 173.1, 143.7, 139.3, 128.6, 128.2, 126.4,
122.9, 121.3, 62.6, 60.5, 58.5, 48.6, 38.3, 37.1, 36.1, 33.8, 29.6, 25.7,
24.1, 10.9. *1,2-dimethylimidazole unreacted: 1H NMR (400 MHz, CDCl3)
δ: 6.88 (s, 1H), 6.81 (d, J = 1.1, 1H), 3.57 (s, 3H), 2.38 (s, 3H). 13C NMR
(100 MHz, CDCl3) δ: 144.9, 127.0, 120.4, 32.8, 12.8. HRMS calculated
20
providing a yellow oil. Yield: 81%. []D = -51 (c 0.9, CH2Cl2). 1H NMR
(400 MHz, CDCl3) δ: 7.37-7.24 (m, 5H), 4.15 (d, J = 10.1, 1H), 4.08 (dd, J
= 7.6 and 11.2, 1H), 4.00 (d, J = 10.1, 1H), 3.88 (dd, J = 6.6 and 11.2,
1H), 3.72-3.64 (m, 1H), 3.67 (d, J = 13.4, 1H), 3.58 (d, J = 13.3, 1H), 3.39
(t, J = 6.7, 2H), 3.08 (dd, J = 6.8 and 10.9, 1H), 2.77 (dd, J = 2.5 and 10.9,
1H), 2.33 (t, J = 7.2, 2H), 1.91-1.83 (m, 2H), 1.69-1.60 (m, 2H), 1.52-1.43
(m, 2H). 13C NMR (100 MHz, CDCl3) δ: 173.0, 138.4, 128.8, 128.4, 127.4,
67.0, 63.9, 58.7, 58.4, 33.9, 33.4, 32.3, 31.9, 27.6, 24.0. HRMS
calculated for [C17H24BrNO2S+H]+: 386,0791; obtained: 386,0749.
for cation [C44H66N6O4S2]2+
: 403,2288; obtained: 403,2292. HRMS
calculated for anion [Br]-: 78,9189; obtained: 78,9154.
4-(9-bromononyl) 3-(tert-butyl) (R)-thiazolidine-3,4-dicarboxylate (11)
1-[(4R)-3-benzyl-thiazolidin-4-yl-methylhexanoate]-2,3-
dimethylimidazolium bromide (3a)
Reagents and amounts used: Protected thiazolidinic acid 10 (2.33 g, 10.0
mmol) obtained in two steps from L-cysteine as previously described[4i,j]
,
dry CH2Cl2 (20 mL), EDCI (1.91 g, 10.0 mmol), DMAP (catalytic) and 9-
bromo-1-nonanol (3.35 g, 15.0 mmol). The residue was purified with
column chromatography using the mixture ethyl acetate:hexane 5:95 as
Reagents and amounts used: Bromide 9 (0.04 g, 0.11 mmol), 1,2-
dimethylimidazole (0.02 g, 0.23 mmol) and acetonitrile (2 mL). The yellow
oil obtained consist of a mixture of the ionic product and the unreacted
1,2-dimethylimidazole in the proportion of 1:1 (ionic product: 1,2-
20
eluent providing a colorless oil. Yield: 63%. []D = -56 (c 0.2, CH2Cl2).
1H NMR (300 MHz, CDCl3, conformers mixture) δ: [4.94-4.84 (m), 4.74-
4.62 (m) and 4.57 (d, J = 8.5), 2H], [4.48 (d, J = 8.8) and 4.41 (d, J = 8.4),
1H], 4.25-4.07 (m, 2H), 3.41 (t, J = 6.8, 2H), 3.38-3.14 (m, 2H), 1.85 (q, J
dimethylimidazole) calculated by H NMR. The mixture of the compound
1
3a with 1,2-dimethylimidazole was solubilized in 2 mL of water and
washed with ethyl ether (6 x 3 mL) to remove the 1,2-dimethylimidazole
unreacted. Then, 3a was extracted with CH2Cl2 and the solvent was
evaporated providing and yellow oil consisting in a mixture of ionic
= 6.9, 2H), 1.72-1.59 (m, 2H), 1.55-1.39 (m, 9H), 1.39-1.21 (m, 10H). 13
C
NMR (75 MHz, CDCl3, conformers mixture) δ: 170.8, 170.4, 153.2, 153.1,
81.08, 65.6, 61.6, 48.9, 48.0, 34.7, 34.0, 33.2, 32.7, 29.2, 29.0, 28.6,
28.5, 28.2, 28.1, 25.7. HRMS calculated for [C18H32BrNO4S+Na]+:
460.1133; obtained: 460.1146.
1
product:1,2-dimethylimidazole 1:0,15 calculated by H NMR. Yield: 99%.
[]D20 = -37 (c 0.7, CH2Cl2). *Product: 1H NMR (400 MHz, CDCl3) δ: 7.70
(d, J = 2.0, 1H), 7.56 (d, J = 2.0, 1H), 7.38-7.24 (m, 5H), 4.24 (t, J = 7.4,
2H), 4.13 (d, J = 10.1, 1H), 4.07 (dd, J = 7.5 and 11.2, 1H), 4.00 (s, 3H),
3.99 (d, J = 10.0, 1H), 3.87 (dd, J = 6.7 and 11.2, 1H), 3.73-3.65 (m, 1H),
3.67 (d, J = 13.3, 1H), 3.58 (d, J = 13.0 1H), 3.09 (dd, J = 6.8 and 10.9,
1H), 2.80 (s, 3H), 2.77 (dd, J = 2.4 and 10.9, 1H), 2.34 (t, J = 7.3, 2H),
1.92-1.80 (m, 2H), 1.70-1.59 (m, 2H), 1.46-1.35 (m, 2H). 13C NMR (100
MHz, CDCl3) δ: 172.1, 143.9, 138.5, 128.9, 128.6, 127.6, 123.2, 121.4,
67.2, 64.2, 58.8, 58.6, 48.8, 36.3, 33.8, 32.1, 29.7, 25.9, 24.2, 11.1. *1,2-
dimethylimidazole unreacted: 1H NMR (400 MHz, CDCl3) δ: 6.89-6.86 (m,
1H), 6.81-6.78 (m, 1H), 3.56 (s, 3H), 2.37 (s, 3H). HRMS calculated for
cation [C22H32N3O2S]+: 402,2210; obtained: 402,2239.
9-bromononyl (R)-thiazolidine-4-carboxylate (12)
A round-bottomed flask was charged with the protected compound
11 (2.7 g, 6.27 mmol) and TFA:CH2Cl2 1:1 solution (20 mL). The reaction
was monitored by thin layer chromatography and was completed in 10
minutes. The solvent was evaporated. To the residue was added water
and the pH was adjusted to 8 by the addition of NaHCO3. The product
was extracted with 3 x 5 mL of CH2Cl2, the organic layer was dried over
MgSO4 and the solvent was evaporated providing an yellow oil without
further purification. Yield: 99%. []D20 = -52 (c 0.5, CH2Cl2). 1H NMR (400
MHz, CDCl3) δ: 4.39 (d, J = 9.6, 1H), 4.18 (t, J = 6.7, 2H), 4.12 (d, J = 9.6,
1H), 3.83 (t, J = 7.6, 2H), 3.41 (t, J = 6.8, 2H), 3.26 (dd, J = 7.2 and 10.4,
1H), 2.87 (dd, J = 7.9 and 10.4, 1H), 2.33 (s, 1H), 1.85 (q, J = 7.1, 2H),
1.66 (q, J = 7.0, 2H), 1.49-1.38 (m, 2H), 1.38-1.27 (m, 8H). 13C NMR
(100 MHz, CDCl3) δ: 171.3, 65.6, 65.3, 54.4, 37.0, 33.9, 32.7, 29.2, 29.0,
28.6, 28.4, 28.1, 25.7. HRMS calculated for [C13H24BrNO2S+H]+:
338,0791; obtained: 338,0816.
1-(nonyl
(R)-thiazolidine-4-carboxylate)-2,3-dimethylimidazolium
bromide (4a)
Reagents and amounts used: Bromide 12 (2.09 g, 6,17 mmol), 1,2-
dimethylimidazole (1.19 g, 12.3 mmol) and acetonitrile (50 mL). The
yellow oil obtained consist of a mixture of the ionic product and the
unreacted 1,2-dimethylimidazole in the proportion of 1:1 (ionic product:
20
1,2-dimethylimidazole) calculated by 1H NMR. Yield: >99%. []D = -36
(c 0.4, CH2Cl2). *Product: 1H NMR (400 MHz, CDCl3) δ: 7.77 (d, J = 2.0,
1H), 7.58 (d, J = 2.1, 1H), 4.36 (d, J = 9.5, 1H), 4.24 (t, J = 7.5, 2H), 4.16
(t, J = 6.7, 2H), 4.12 (d, J = 9.5, 1H), 4.03 (s, 3H), 3.90 (t, J = 7.3, 1H),
General procedure to generate the ionic species containing
imidazolium cation
This article is protected by copyright. All rights reserved.